When a couple struggles to conceive, the instinct — in clinical settings and at home — is to start with her. Her cycle, her hormones, her ovulation. This is understandable. It is also costing couples months, and sometimes years, they do not need to lose.

The data is unambiguous: male factor is involved in somewhere between 50 and 70% of infertility cases. Not as a rare secondary concern — as a primary driver, half the time. Yet semen analysis is still treated as the test you run after everything else has been checked, if it gets run at all.

What the statistics actually show

Infertility is clinically defined as 12 consecutive months of trying to conceive without a pregnancy. When researchers break down the causes, the picture looks like this:

This does not change based on prior pregnancies. Sperm quality and concentration shift over time, affected by age, health, stress, illness, and lifestyle. A previous successful conception — in this relationship or a past one — is not a current result. Testing still matters.

Why “normal” doesn’t mean what it sounds like

The reference range most clinics use comes from WHO guidelines. Under those guidelines, a sperm concentration of 15 million per millilitre is considered normal. A man who hits that number is typically told everything looks fine.

What that framing leaves out: 15 million/mL is the 5th percentile. It was derived from a dataset of men who did achieve pregnancy with their partners within 12 months — but the threshold was drawn at the very bottom of that group. Ninety-five percent of those men had better numbers. The threshold was not placed where success is likely. It was placed at the floor of the range where it has occasionally been shown to work.

At 15 million/mL, the estimated per-cycle probability of conception is approximately 5%. That is the number being rubber-stamped as acceptable in clinical semen analysis reporting.

The 50th percentile of that same dataset — the midpoint of men who successfully conceived — sits around 73 million per millilitre. A practical target for optimisation is above 60 million/mL. That gap, between what clears the bar and what actually reflects fertility potential, is not a minor technical distinction. It is where most couples who are told “nothing is wrong” are quietly losing time.

Where the real drop-off happens

Pregnancy probability by sperm concentration is not a linear curve. The steepest decline happens below 30 million/mL — which is still well above the WHO minimum threshold that triggers no clinical concern.

Above 50 million/mL, per-cycle pregnancy probability plateaus near 20–25% — a ceiling that reflects biological limits, not sperm count. Getting from 60 million to 100 million makes little practical difference. Getting from 15 million to 60 million makes a significant one.

Subfertility vs. infertility — and why the gap matters

One reason male factor gets missed is that clinical concern is triggered by infertility thresholds, not subfertility. If a result clears 15 million/mL, it does not prompt a referral or a follow-up conversation. But a man at 25 million/mL is not in the same position as one at 70 million/mL — and treating those results as equivalent is how couples end up in a prolonged stretch of “keep trying” that didn’t need to last as long as it did.

Subfertility — results that are technically within range but far from optimal — is common and, in many cases, improvable. The research base for male fertility nutrition, lifestyle, and supplementation is more robust than most people realise, partly because sperm concentration is a measurable, repeatable endpoint that is straightforward to study. Randomised controlled trials exist. The evidence base is there. But it cannot be applied well without knowing what the actual numbers are.

Getting tested — and reading the results correctly

A clinical semen analysis — where the sample is produced and analysed on-site at a lab — remains the most reliable method. At-home testing has improved; one option used in fertility-focused clinical programmes is Fellow, which runs morphology and returns actual numerical data rather than a simplified pass/fail result. If at-home results come back low or irregular, confirming with a clinical sample before building any treatment plan is the sensible next step.

When results come back, the question is not just whether concentration clears 15 million/mL. It is where concentration sits relative to the 50th-percentile target. Below 60 million/mL, there is room for improvement. Below 30 million/mL, understanding why — structural, hormonal, or lifestyle-related — should come before any intervention is started.

Testing is the beginning of a plan, not the end of a conversation.

---